D-Mannose vs Cranberry: Which Has Evidence Behind It?

We cannot rank them, because our sources cover only one. Cranberry has trial evidence behind it. D-mannose is not covered by any health source we cite.

That gap is not a verdict on D-mannose. It means we have no opened source, so we state no benefit, no dose and no risk for it. A pharmacist or clinician can speak to it with your history in hand.

What we can offer is a clear account of cranberry, so you know the yardstick another product must meet.

FemiCore contains cranberry and no D-mannose. The Herbal Blend lists Mimosa pudica seed extract, cranberry extract standardized to 30% proanthocyanidin, bearberry leaf and berberine extract. The other ingredients are gelatin, brown rice flour, magnesium stearate, olive oil and silicon dioxide.

Cranberry is line 2 of 4 in a 350 mg blend, so it weighs at most 175 mg (21 CFR 101.36, supplement labeling). The label prints no real weight, and the Cochrane result is about cranberry products, not a multi-ingredient capsule (Cochrane 2023, cranberries and UTI).

No trial of FemiCore itself is published. Read the cranberry page for the line-by-line view.

1. Label front“Healthy Urinary System†”Structure/function wording, allowed with the FDA statement. Not a disease claim, and FDA did not review it. (21 CFR 101.93, structure/function claims)
2. Label front“Bladder Control Support†”No trial of FemiCore was found. None of the nine lines has a bladder-control trial; the first-line care for leaks is pelvic floor and bladder training. (NICE NG123, incontinence in women) (Cochrane, PFMT for incontinence)
3. Label front“Microbiome Balance†”Effects are strain-specific, and no CFU count is printed. The one strain with a registered trial (LCr86) was tested at a stated dose for a vaginal outcome. (ClinicalTrials.gov NCT06830122, LCr86)
4. Label front“Clinically Researched Ingredients”Some ingredients have research for other uses (cranberry and repeat UTIs, berberine and blood sugar). That is not research on this capsule. (Cochrane 2023, cranberries and UTI) (NCCIH, Cranberry)
5. Sales page“scientifically proven”No study is named on the sales text we reviewed. A claim like this needs competent and reliable evidence. (FTC, Health Products Compliance Guidance)
6. Sales page“The Natural Breakthrough Formula That Supports a Strong Bladder”Marketing language. Bearberry is a one-week herb in EU guidance, not a daily, long-term one. (EMA, Uvae ursi folium (bearberry leaf))
7. Sales page60-day money-back badgesThe images show 60 days; the written terms are not printed on the sales text. We count from the date of purchase. (FemiCore sales page)

Claims as printed on the label and the sales page (FemiCore sales page). Health claims need competent and reliable scientific evidence (FTC, Health Products Compliance Guidance).

Choose with a clinician who knows your history. Two or more UTIs in 6 months, or three in 12, counts as recurrent, and NICE lists behavioral steps first (NICE NG112, recurrent UTI).

Ask what each option has been studied for, in whom, and at what dose. If an answer rests on a sales page, ask for the study.

Write down your trips and any burning in a three-day diary first. A clinician can then see whether the pattern points to infection, to bladder habits or to something else, and which of those a supplement could even address (Mayo Clinic, incontinence treatment).

The FemiCore sales page shows $79 a bottle on two, $69 on three and $49 on six. Keep taking any prescribed medicine.